What is InsightRX?
InsightRX specializes in providing model-informed precision dosing and clinical decision support solutions tailored for life science and healthcare providers. Their advanced platform enables healthcare organizations to customize treatments based on individual patient pharmacological profiles, aiming to enhance patient outcomes across various therapeutic areas, including infectious disease and bone marrow transplant. Furthermore, InsightRX's real-time clinical analytics and precision dosing tools are instrumental in supporting drug development processes for biopharma clients, thereby maximizing the efficacy and safety of new medications. The company is dedicated to minimizing adverse drug events and elevating the overall patient care experience, serving a broad spectrum of healthcare providers and biopharmaceutical entities.
How much funding has InsightRX raised?
InsightRX has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2019): $10M, investors not publicly disclosed
What's next for InsightRX?
With the infusion of major enterprise-level funding, InsightRX is poised for accelerated growth and market expansion. The substantial capital injection is expected to fuel further development of their precision dosing and clinical decision support technologies, potentially leading to broader adoption within the healthcare and life sciences sectors. This strategic investment will likely enable InsightRX to enhance its platform capabilities, scale its operations, and forge new partnerships, solidifying its position as a key player in the precision medicine revolution. The company's focus on improving patient outcomes and supporting drug development indicates a trajectory towards becoming an indispensable tool for healthcare providers and biopharmaceutical innovators.
See full InsightRX company page
